ℹ️
🇬🇧
Search
Search for people relevant for "Potential"
Potential
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. Yvona Mazurová CSc.
Academic staff at Faculty of Medicine in Hradec Králové
12 classes
212 publications
Classes
class
Histology and Embryology I
+3
FD10004 |
Faculty of Medicine in Hradec Králové
class
Histology and Embryology II
+3
FD10021 |
Faculty of Medicine in Hradec Králové
class
Selected Topics from Orofacial Histology and Embryology
+3
FD50001 |
Faculty of Medicine in Hradec Králové
Load more classes (2)
Publications
publication
Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits
2013 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity
+1
2009 |
Faculty of Medicine in Hradec Králové
publication
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Anthracycline cardiotoxicity and the possibility of the pharmacological cardioprotection
2007 |
Faculty of Medicine in Hradec Králové
publication
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity
+1
2006 |
Faculty of Medicine in Hradec Králové
publication
Study of potential cardioprotective effects of a novel iron chelator (pyridoxal 2-chlorobenzoyl hydrazone; o-108) in daunorubicin cardiotoxicity in rabbits
Publication without faculty affiliation
publication
Dětská urologie
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
publication
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up
2022 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo
2021 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation
2021 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
Load more publications (202)
Loading network view...